Abstract
Interferon-gamma (IFN-γ) and interleukin-4 (IL-4) represent T helper 1 (Th1) and T helper 2 (Th2) cytokines involved in oral lichen planus (OLP), respectively. This study was to investigate the expression profile of IFN-γ and IL-4 in saliva of OLP patients. Seventy-nine ethnic Chinese patients with OLP were recruited for this study, together with 41 age–sex-matched healthy volunteers served as control group. IFN-γ and IL-4 levels in whole unstimulated saliva were screened by enzyme linked immunosorbent assay. OLP patient showed a low-level IFN-γ but high-level IL-4 expression profile in saliva, with a lower ratio of salivary IFN-γ/IL-4 compared to healthy controls. With regards to subtypes, salivary IL-4 level in erythematous/ulcerative group was significantly higher than that in reticular group. Imbalance of Th1/Th2 cytokines with Th2-predominant profile in saliva may be involved in OLP. Salivary IL-4 level may be a fine biomarker reflecting the severity of OLP.
Similar content being viewed by others
References
Sugerman, P. B., N. W. Savage, L. J. Walsh, Z. Z. Zhao, X. J. Zhou, A. Khan, G. J. Seymour, and M. Bigby. 2002. The pathogenesis of oral lichen planus. Crit. Rev. Oral Biol. Med. 13(4):350–365. doi:10.1177/154411130201300405.
Sugerman, P. B., and N. W. Savage. 2002. Oral lichen planus: causes, diagnosis and management. Aust. Dent. J. 47(4):290–297. doi:10.1111/j.1834-7819.2002.tb00540.x.
Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 2005. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J. Immunol. 175(1):5–14.
Constant, S. L., and K. Bottomly. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297–322. doi:10.1146/annurev.immunol.15.1.297.
Rengarajan, J., S. J. Szabo, and L. H. Glimcher. 2000. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today. 21(10):479–483. doi:10.1016/S0167-5699(00)01712-6.
Gor, D. O., N. R. Rose, and N. S. Greenspan. 2003. TH1–TH2: a procrustean paradigm. Nat. Immunol. 4(6):503–505. doi:10.1038/ni0603-503.
Hamzaoui, K., A. Hamzaoui, F. Guemira, M. Bessioud, M. Hamza, and K. Ayed. 2002. Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand. J. Rheumatol. 31(4):205–210. doi:10.1080/030097402320318387.
Ramos-Casals, M., M. Garcia-Carrasco, R. Cervera, X. Filella, O. Trejo, G. de la Red, V. Gil, J. M. Sanchez-Tapias, J. Font, and M. Ingelmo. 2002. Th1/Th2 cytokine imbalance in patients with Sjogren syndrome secondary to hepatitis C virus infection. Semin. Arthritis. Rheum. 32(1):56–63. doi:10.1053/sarh.2002.33724.
Rhodus, N. L., B. Cheng, and F. Ondrey. 2007. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm. 2007:19854. doi:10.1155/2007/19854.
Kaufman, E., and I. B. Lamster. 2002. The diagnostic applications of saliva—a review. Crit. Rev. Oral Biol. Med. 13(2):197–212. doi:10.1177/154411130201300209.
Tao, X. A., C. Y. Li, N. L. Rhodus, J. Xia, X. P. Yang, and B. Cheng. 2008. Simultaneous detection of IFN-gamma and IL-4 in lesional tissues and whole unstimulated saliva from patients with oral lichen planus. J. Oral Pathol. Med. 37(2):83–87.
Zhang, Y., M. Lin, S. Zhang, Z. Wang, L. Jiang, J. Shen, J. Bai, F. Gao, M. Zhou, and Q. Chen. 2008. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine. 41(2):144–149. doi:10.1016/j.cyto.2007.11.004.
Al-Hashimi, I., M. Schifter, P. B. Lockhart, D. Wray, M. Brennan, C. A. Migliorati, T. Axell, A. J. Bruce, W. Carpenter, E. Eisenberg, J. B. Epstein, P. Holmstrup, M. Jontell, F. Lozada-Nur, R. Nair, B. Silverman, K. Thongprasom, M. Thornhill, S. Warnakulasuriya, and I. van der Waal. 2007. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103(Suppl:S25):e21–e12.
Lozada-Nur, F., and C. Miranda. 1997. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin. Cutan. Med. Surg. 16(4):273–277. doi:10.1016/S1085-5629(97)80016-8.
Navazesh, M. 1993. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 694:72–77. doi:10.1111/j.1749-6632.1993.tb18343.x.
Wurtz, O., M. Bajenoff, and S. Guerder. 2004. IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms. Int. Immunol. 16(3):501–508. doi:10.1093/intimm/dxh050.
Khan, A., C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman. 2003. Th1 cytokines in oral lichen planus. J. Oral Pathol. Med. 32(2):77–83. doi:10.1034/j.1600-0714.2003.00077.x.
Simark-Mattsson, C., G. Bergenholtz, M. Jontell, C. Eklund, G. J. Seymour, P. B. Sugerman, N. W. Savage, and U. I. Dahlgren. 1999. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch. Oral Biol. 44(6):499–507. doi:10.1016/S0003-9969(99)00013-8.
Neurath, M. F., S. Finotto, and L. H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8(6):567–573. doi:10.1038/nm0602-567.
Carrozzo, M., M. Uboldi de Capei, E. Dametto, M. E. Fasano, P. Arduino, R. Broccoletti, D. Vezza, S. Rendine, E. S. Curtoni, and S. Gandolfo. 2004. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J. Invest. Dermatol. 122(1):87–94. doi:10.1046/j.0022-202X.2003.22108.x.
Bai, J., M. Lin, X. Zeng, Y. Zhang, Z. Wang, J. Shen, L. Jiang, F. Gao, and Q. Chen. 2008. Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: a study in an ethnic Chinese cohort. J. Interferon Cytokine Res. 28(6):351–358. doi:10.1089/jir.2007.0056.
Yamamoto, T., K. Yoneda, E. Ueta, and T. Osaki. 1990. Cellular immunosuppression in oral lichen planus. J. Oral Pathol. Med. 19(10):464–470. doi:10.1111/j.1600-0714.1990.tb00788.x.
Simark Mattsson, C., M. Jontell, G. Bergenholtz, M. Heyden, and U. I. Dahlgren. 1998. Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions. J. Oral Pathol. Med. 27(10):483–488.
Karagouni, E. E., E. N. Dotsika, and A. Sklavounou. 1994. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J. Oral Pathol. Med. 23(1):28–35. doi:10.1111/j.1600-0714.1994.tb00250.x.
Zhou, G., M. W. Fan, and J. Y. Liu. 2005. [Effects of glucocorticoids on T helper cells balance in oral lichen planus]. Zhonghua Kou Qiang Yi Xue Za Zhi. 40(2):98–101.
Yamamoto, T., and T. Osaki. 1995. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J. Invest. Dermatol. 104(5):784–788. doi:10.1111/1523-1747.ep12606990.
Yamamoto, T., K. Yoneda, E. Ueta, J. Hirota, and T. Osaki. 1991. Serum cytokine levels in patients with oral mucous membrane disorders. J. Oral Pathol. Med. 20(6):275–279. doi:10.1111/j.1600-0714.1991.tb00927.x.
Eisen, D., M. Carrozzo, J. V. Bagan Sebastian, and K. Thongprasom. 2005. Number V oral lichen planus: clinical features and management. Oral Dis. 11(6):338–349. doi:10.1111/j.1601-0825.2005.01142.x.
Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8(3):223–246.
Ghoreschi, K., P. Thomas, S. Breit, M. Dugas, R. Mailhammer, W. van Eden, R. van der Zee, T. Biedermann, J. Prinz, M. Mack, U. Mrowietz, E. Christophers, D. Schlondorff, G. Plewig, C. A. Sander, and M. Rocken. 2003. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9(1):40–46. doi:10.1038/nm804.
Zakrzewska, J. M., E. S. Chan, and M. H. Thornhill. 2005. A systematic review of placebo-controlled randomized clinical trials of treatments used in oral lichen planus. Br. J. Dermatol. 153(2):336–341. doi:10.1111/j.1365-2133.2005.06493.x.
Racke, M. K., D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154(1):450–458.
Funauchi, M., S. Ikoma, H. Enomoto, and A. Horiuchi. 1998. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand. J. Rheumatol. 27(3):219–224. doi:10.1080/030097498440859.
Richaud-Patin, Y., J. Alcocer-Varela, and L. Llorente. 1995. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev. Invest. Clin. 47(4):267–272.
Fayyazi, A., S. Schweyer, A. Soruri, L. Q. Duong, H. J. Radzun, J. Peters, R. Parwaresch, and H. Berger. 1999. T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. Arch. Dermatol. Res. 291(9):485–490. doi:10.1007/s004030050442.
Yamamoto, T., K. Yoneda, E. Ueta, and T. Osaki. 1994. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg. Oral Med. Oral Pathol. 78(6):727–735. doi:10.1016/0030-4220(94)90087-6.
Yamamoto, T., T. Osaki, K. Yoneda, and E. Ueta. 1994. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus.. J. Oral Pathol. Med. 23(7):309–315. doi:10.1111/j.1600-0714.1994.tb00067.x.
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772424, 30672323) and Scientific Research Foundation for Medicine and Health from Health Bureau of Zhejiang Province (No. 2007A132). We appreciate Dr. Shu Yang and Keli Chen from West China School of Public Health, Sichuan University, Peoples’ Republic of China for their statistic analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, W., Dan, H., Wang, Z. et al. IFN-Gamma and IL-4 in Saliva of Patients with Oral Lichen Planus: A Study in an Ethnic Chinese Population. Inflammation 32, 176–181 (2009). https://doi.org/10.1007/s10753-009-9118-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-009-9118-2